Abstract
The population genotype and allele frequencies of +49A/G of the cytotoxic T-lymphocyte antigen 4 gene (CTLA4); −1858C/T of the protein tyrosine phosphatase gene (PTPN22); and −23HphIA/T of the insulin gene (INS) were detected in ethnic Belarusians from six ethnogeographical regions. Frequencies of the risk allele homozygous carriers were 17.3% for the CTLA4 gene +49G, 50.7% for the insulin gene −23HphIA, and 4.1 for the PTPN22 gene −1858T. The homozygous risk genotype of all three loci was detected in five individuals of 662 individuals tested; the homozygous combination of protective alleles was detected in 21 individuals. The similarity in the allele and genotype distribution of the studied loci on the territory of Belarus was demonstrated.
Similar content being viewed by others
References
Abramov, D.D., Dedov, I.I., Trofimov, D.Yu., et al., Polymorphism of the CTLA4 (49A/G) Gene in the Russian Population in Patients with Type 1 Diabetes Mellitus and Healthy Volunteers, Sakharnyi Diabet, 2007, vol. 3, pp. 2–3.
Andreevskii, T.V., Sudomoina, M.A., Gusev, E.I., et al., A/G Polymorphism at Position +49 of Exon 1 of the CTLA4 Gene in Multiple Sclerosis in Russian Population, Mol. Biol. (Moscow), 2002, vol. 36, pp. 643–648.
Baranov, V.S., Baranova, E.V., and Ivashchenko, T.E., Scientific Basis of Predictive Medicine, in Molekulyarnobiologicheskie tekhnologii v meditsinskoi praktike (Molecular-Biological Technologies in Medical Practice), Novosibirsk: Al’fa-Vista, 2003, pp. 3–19.
Zdravookhranenie v Respublike Belarus’. Ofitsial’nyi statisticheskii sbornik za 2008 g (Healthcare in the Republic of Belarus. The Official Statistical Abstract for 2008), Minsk: GU RNMB, 2009.
Rokitskii, P.F., Biologicheskaya statistika (Biological Statistics), Minsk: Vysshaya shkola, 1964.
Albert, L.J. and Inman, R.D., Molecular Mimicry and Autoimmunity, N. Engl. J. Med., 1999, vol. 341, pp. 2068–2074.
Beland, K., Lapierre, P., and Alvarez, F., Influence of Genes, Sex, Age and Environment on the Onset of Autoimmune Hepatitis, World J. Gastroenterol., 2009, vol. 15, pp. 1025–1034.
Bell, G.I., Karam, J.H., and Rutter, W.J., Polymorphic DNA Region Adjacent to the 5’end of the Human Insulin Gene, Proc. Nat. Acad. Sci. USA, 1981, vol. 78, pp. 5759–5763.
Benedek, G., Brautbar, C., Vardi, P., et al., Effect of Polymorphism in Insulin Locus and HLA on Type 1 Diabetes in Four Ethnic Groups in Israel, Tissue Antigens, 2009, vol. 73, pp. 33–38.
Butty, V., Campbell, C., Mathis, D., et al., Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial-Type 1 (DPT-1), Diabetes, 2008, vol. 57, pp. 2348–2359.
Cejkova, P., Novota, P., Cerna, M., et al., HLA DRB1, DQB1 and Insulin Promoter VNTR Polymorphisms: Interactions and the Association with Adult Onset Diabetes Mellitus in Czech Patients, Int. J. Immunogenet., 2008, vol. 35, pp. 133–140.
Chabchoub, G., Teixiera, E.P., Maalej, A., et al., The R620W Polymorphism of the Protein Tyrosine Phosphatase 22 Gene in Autoimmune Thyroid Diseases and Rheumatoid Arthritis in the Tunisian Population, Ann. Hum. Biol., 2009, vol. 36, pp. 342–349.
Coyle, A.J., Lehar, S., Lloyd, C., et al., The CD28related Molecule ICOS Is Required for Effective T Cell-Dependent Immune Responses, Immunity, 2000, vol. 13, pp. 95–105.
Day, I.N.M., Rodriguez, S., and Krloviov, J., Questioning INS VNTR Role in Obesity and Diabetes: Subclasses Tag IGF2-INS-TH Haplotypes; and −23HphI as a STEP (Splicing and Translational Efficiency Polymorphism), Physiol. Genomics, 2006, vol. 28, p. 113.
Dieud, P., Garnier, S., Michou, L., et al., Rheumatoid Arthritis Seropositive for the Rheumatoid Factor Is Linked to the Protein Tyrosine Phosphatase Nonreceptor 22-620W Allele, Arthritis Res. Ther., 2005, vol. 7, pp. R1200–R1207.
Donner, H., Rau, H., Walfish, P.G., et al., CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus, J. Clin. Endocrinol. Metab., 1997, vol. 82, pp. 143–146.
Farago, B., Talian, G.C., Komlosi, K., et al., Protein Tyrosine Phosphatase Gene C1858T Allele Confers Risk for Rheumatoid Arthritis in Hungarian Subjects, Rheumatol. Int., 2008, vol. 29, pp. 793–796.
Forebosco, P., Bouzigon, E., Ng, M.Y., et al., Metaanalysis of Genome-Wide Linkage Studies across Autoimmune Diseases, Eur. J. Hum. Genet., 2009, vol. 17, pp. 236–243.
Gale, E.A., The Rise of Childhood Type 1 Diabetes in the 20th Century, Diabetes, 2002, vol. 51, pp. 3353–3361.
Guja, C., Guja, L., Nutland, S., et al., Strong Association of Insulin Gene INS-VNTR Polymorphisms with Type 1 Diabetes in the Romanian Population, Rom. J. Int. Med., 2004, vol. 42, pp. 313–323.
Kennedy, G.C., German, M.S., and Rutter, W.J., The Minisatellite in the Diabetes Susceptibility Locus IDDM2 Regulates Insulin Transcription, Nat. Genet., 1995, vol. 9, pp. 293–298.
Kim, M.S. and Polychronakos, C., Immunogenetics of Type 1 Diabetes, Horm. Res., 2005, vol. 64, pp. 180–188.
Knip, M., Veijola, R., Virtanen, S.M., et al., Environmental Triggers and Determinants of Type 1 Diabetes, Diabetes, 2005, vol. 54,suppl. 2, pp. S125–S136.
Kochi, Y., Suzuki, A., Yamada, R., and Yamamoto, K., Genetics of Rheumatoid Arthritis: Underlying Evidence of Ethnic Differences, J. Autoimmun, 2009, vol. 32, pp. 158–162.
Korolija, M., Renar, I.P., Hadija, M., et al., Association of PTPN22 C1858T and CTLA4 A49G Polymorphisms with Type 1 Diabetes in Croatians, Diabetes Res. Clin. Pract., Oct. 6, 2009 [Epub ahead of print].
Kouki, T., Sawai, Y., Gardine, C.A., et al., CTLA4 Gene Polymorphism at Position 49 of Exon 1 Reduces the Inhibitory Function of CTLA4 and Contributes to the Pathogenesis of Graves’ Disease, J. Immunol., 2000, vol. 165, pp. 6606–6611.
Krechler, T., Jachymova, M., Pavlikova, M., et al., Polymorphism −23HphI in the Promoter of Insulin Gene and Pancreatic Cancer: A Pilot Study, Neoplasma, 2009, vol. 56, pp. 26–32.
Kristiansen, O.P., Larsenand, Z.M., and Pociot, F., CTLA4 in Autoimmune Diseases-A General Susceptibility Gene to Autoimmunity?, Genes Immun., 2000, vol. 1, pp. 170–184.
Krokowski, M., Bodalski, J., Bratek, A., et al., CTLA4 Gene Polymorphism Is Associated with Predisposition to IDDM in a Population from Central Poland, Diabetes Metab., 1998, vol. 24, pp. 241–243.
Lee, H.S., Korman, B.D., Le, J.M., et al., Genetic Risk Factors for Rheumatoid Arthritis Differ in Caucasian and Korean Populations, Arthritis Rheum., 2009, vol. 60, pp. 364–371.
Lee, S.Y., Lee, Y.H., Shin, C., et al., Association of Asthma Severity and Bronchial Hyperresponsiveness with a Polymorphism in the Cytotoxic T-Lymphocyte Antigen4 Gene, Chest, 2002, vol. 122, pp. 171–176.
Lempainena, J., Vaaralac, O., Mkela, M., et al., Interplay between PTPN22 C1858T Polymorphism and Cow’s Milk Formula Exposure in Type 1 Diabetes, J. Autoimmun., 2009, vol. 33, pp. 155–164.
Marron, M.P., Raffel, L.J., Garchon, H.-J., et al., Insulin-Dependent Diabetes Mellitus (IDDM) Is Associated with CTLA4 Polymorphisms in Multiple Ethnic Groups, Hum. Mol. Genet., 1997, vol. 6, pp. 1275–1282.
Maya, R., Gershwin, M.E., and Shoenfeld, Y., Hepatitis B Virus (HBV) and Autoimmune Disease, Clin. Rev. Allergy Immunol., 2008, vol. 34, pp. 85–102.
Meyer, U.A. and Gut, J., Genomics and the Prediction of Xenobiotic Toxicity, Toxicology, 2002, vol. 181–182, pp. 463–466.
Mitchell, S.M.S., Hattersley, A.T., Knight, B., et al., Lack of Support for a Role of the Insulin Gene Variable Number of Tandem Repeats Minisatellite (INS-VNTR) Locus in Fetal Growth Or Type 2 Diabetes-Related Intermediate Traits in United Kingdom Populations, J. Clin. Endocrinol. Metab., 2004, vol. 89, pp. 310–317.
Miyake, K., Yang, W., Hara, K., et al., Construction of a Prediction Model for Type 2 Diabetes Mellitus in the Japanese Population Based on 11 Genes with Strong Evidence of the Association, J. Hum. Genet., 2009, vol. 54, pp. 236–241.
Mojtahedi, Z., Omrani, G.R., Doroudchi, M., and Ghaderi, A., CTLA4 +49 A/G Polymorphism Is Associated with Predisposition to Type 1 Diabetes in Iranians, Diabetes Res. Clin. Pract., 2005, vol. 68, pp. 111–116.
Pierer, M., Kaltenhuser, S., Arnold, S., et al., Association of PTPN22 1858 Single-Nucleotide Polymorphism with Rheumatoid Arthritis in a German Cohort: Higher Frequency of the Risk Allele in Male Compared to Female Patients, Arthritis Res. Ther., 2006, vol. 8, p. R75. doi:10.1186/ar1945, http://arthritis-research.com/content/8/3/R75.
Prummel, M.F., Strieder, T., and Wiersinga, W.M., The Environment and Autoimmune Thyroid Diseases, Eur. J. Endocrinol., 2004, vol. 150, pp. 605–618.
Sahin, N., Gunduz, F., Inanc, N., et al., No Association of PTPN22 Gene Polymorphism with Rheumatoid Arthritis in Turkey, Rheumatol. Int., Apr. 9, 2009 [Epub ahead of print]. DOI 10.1007/s00296-009-0919-2.
Santiago, J.L., Martnez, A., Calle, H., et al., Susceptibility to Type 1 Diabetes Conferred by the PTPN22 C1858T Polymorphism in the Spanish Population, BMC Med Genet., 2007, vol. 8, p. 54. http://www.biomedcentral.com/1471-2350/8/54.
Smith, D.A. and Germolec, D.R., Introduction to Immunology and Autoimmunity, Environ. Health Perspect., 1999, vol. 107, pp. 661–665.
Steck, A.K., Zhang, W., Bugawan, T.L., et al., Do Non-HLA Genes Influence Development of Persistent Islet Autoimmunity and Type 1 Diabetes in Children with High-Risk HLA-DR, DQ Genotypes?, Diabetes, 2009, vol. 58, pp. 1028–1033.
Stene, L.C., Thorsby, P.M., Berg, J.P., et al., The Relation between Size at Birth and Risk of Type 1 Diabetes Is Not Influenced by Adjustment for the Insulin Gene (-23HphI) Polymorphism Or HLA-DQ Genotype, Diabetologia, 2006, vol. 49, pp. 2068–2073.
Tait, K.F., Collins, J.E., Heward, J.M., et al., Evidence for a Type 1 Diabetes-Specific Mechanism for the Insulin Gene-Associated IDDM2 Locus Rather Than a General Influence on Autoimmunity, Diabet. Med., 2004, vol. 21, pp. 267–270.
Ueda, H., Howson, J.M., Esposito, L., et al., Association of the T-Cell Regulatory Gene CTLA4 with Susceptibility to Autoimmune Disease, Nature, 2003, vol. 423, pp. 506–511.
Vaidya, B., Pearce, S.H.S., Charlton, S., et al., An Association between the CTLA4 Exon 1 Polymorphism and Early Rheumatoid Arthritis with Autoimmune Endocrinopathies, Rheumatology, 2002, vol. 41, pp. 180–183.
Vang, T., Congia, M., Macis, M.D., et al., Autoimmune-Associated Lymphoid Tyrosine Phosphatase Is a Gainoffunction Variant, Nat. Genet., 2005, vol. 37, pp. 1317–1319.
Villano, M.J., Huber, A.K., Greenberg, D.A., et al., Autoimmune Thyroiditis and Diabetes: Dissecting the Joint Genetic Susceptibility in a Large Cohort of Multiplex Families, J. Clin. Endocrinol. Metab., 2009, vol. 94, pp. 1458–1466.
Vyse, T.J. and Todd, J.A., Genetic Analysis of Autoimmune Disease, Cell, 1996, vol. 85, pp. 311–318.
Whitacre, C.C., Sex Differences in Autoimmune Disease, Nat. Immunol., 2001, vol. 2, pp. 777–780.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.A. Aksyonova, T.N. Pokladok, D.V. Boiko, N.G. Danilenko, 2010, published in Ekologicheskaya Genetika, 2010, Vol. 8, No. 1, pp. 50–58.
Rights and permissions
About this article
Cite this article
Aksyonova, E.A., Pokladok, T.N., Boiko, D.V. et al. Risk allele frequencies of several genes controlling the development of autoimmune pathologies in the population of belarus. Russ J Genet Appl Res 1, 402–410 (2011). https://doi.org/10.1134/S2079059711050029
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079059711050029